PAM
NVO

Pinpoint Asset Management’s Novo Nordisk NVO Stock Holding History

Pinpoint Asset Management’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		$1.1M Sell
2,692
-6,546
-71% -$541K 0.19% 41
2024
Q4 		$795K Sell
9,238
-26,628
-74% -$2.88M 0.14% 40
2024
Q3 		$4.27M Buy
35,866
+500
+1% +$66.7K 0.92% 16
2024
Q2 		$5.05M Sell
35,366
-1,683
-5% -$223K 0.71% 23
2024
Q1 		$4.76M Buy
+37,049
New +$4.41M 0.76% 24

Other funds holding NVO

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
TIM
Thornburg Investment Management Santa Fe, New Mexico $9.63B AUM 35.65% 1-Year Est. Return

Pinpoint Asset Management's NVO Position: Q1 2025 in Review

Pinpoint Asset Management reduced its Novo Nordisk (NVO) stake by 71% in Q1 2025, selling an estimated $541K and leaving 2,692 shares worth $1.1M. The position accounts for 0.19% of the portfolio, ranked #41.

Pinpoint Asset Management first reported a position in NVO in Q1 2024 and has held it in 5 quarters since. The position peaked at $5.05M in Q2 2024. 1,528 funds tracked by Wall St. Rank hold NVO as of Q1 2025.

  • Pinpoint Asset Management held 2,692 shares of Novo Nordisk worth $1.1M as of Q1 2025.
  • Pinpoint Asset Management sold 6,546 Novo Nordisk shares in Q1 2025, an estimated $541K.
  • Novo Nordisk made up 0.19% of Pinpoint Asset Management's portfolio in Q1 2025, its #41 holding.
  • Pinpoint Asset Management first reported a position in Novo Nordisk in Q1 2024 and has held it in 5 quarters since.
  • Pinpoint Asset Management's Novo Nordisk position peaked at $5.05M in Q2 2024.
  • 1,528 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2025.

Based on Pinpoint Asset Management's 13F filing for Q1 2025, filed 12 May 2025.